基因组测序信息对先天性心脏病患儿医师治疗推荐的影响
该研究采用概率抽样纳入美国202名照护危重先天性心脏病(CHD)患儿的心脏内科医师、心脏外科医师、新生儿科医师和重症监护医师,使用情景案例(vignette)方法随机分配不同患者场景和不同基因组信息,随后报告推荐特定治疗选项的可能性。参与医师中98.3%曾见过基因检测结果,84.5%曾用结果做临床照护推荐,67.5%曾见过基因组测序结果,37.9%曾用基因组测序结果做治疗推荐。调查实验显示,收到预测智力障碍、自闭症或儿童期癌症综合征的基因组测序结果,各自独立显著降低医师推荐手术姑息、体外膜肺氧合(ECMO)或心脏移植的可能性。作者认为这提示基因组结果可能影响医师关于是否放弃或撤除某些治疗选项的推荐,并提出重要伦理问题需未来仔细考虑。
要点
- 收到预测智力障碍的基因组测序结果,独立显著降低医师推荐手术姑息、ECMO或心脏移植的可能性。
- 收到预测自闭症的基因组测序结果,独立显著降低医师推荐手术姑息、ECMO或心脏移植的可能性。
- 收到预测儿童期癌症综合征的基因组测序结果,独立显著降低医师推荐手术姑息、ECMO或心脏移植的可能性。
- 参与调查的202名医师中,67.5%曾见过基因组测序结果,37.9%曾用基因组测序结果做治疗推荐。
- 作者认为基因组结果可能影响危重CHD患儿是否放弃或撤除某些治疗的推荐,提出重要伦理问题需未来仔细考虑。
适用人群与场景
- 美国照护危重先天性心脏病(CHD)患儿的心脏内科医师、心脏外科医师、新生儿科医师和重症监护医师,概率样本202名。
研究设计与关键结果
- 研究类型为采用情景案例(vignette)方法的调查实验,概率样本202名美国照护危重CHD患儿的医师,随机分配不同患者场景和不同基因组信息,报告推荐特定治疗选项的可能性。
- 参与医师中98.3%曾见过基因检测结果,84.5%曾用结果做临床照护推荐,67.5%曾见过基因组测序结果,37.9%曾用基因组测序结果做治疗推荐。
- 调查实验中,收到预测智力障碍、自闭症或儿童期癌症综合征的基因组测序结果,各自独立显著降低医师推荐手术姑息、ECMO或心脏移植的可能性。
证据类型、等级与局限
- 证据类型:调查实验(概率样本202名医师,情景案例方法)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,照护危重CHD患儿的医师在推荐是否放弃或撤除某些治疗选项时,可能受基因组结果影响,这提出重要伦理问题需未来仔细考虑。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Genomic sequencing (GS) is increasingly part of diagnostic evaluations of children with congenital heart disease (CHD). Past research suggests that clinicians might envision the most immediate benefits of GS to be guidance in decisions regarding withdrawal of care and rationing of scarce resources. This study sought to document whether providing GS information to physicians caring for critically ill children with CHD might lead them to alter recommendations regarding care strategies.
METHODS: A probability sample of 202 cardiologists, cardiac surgeons, neonatologists, and critical-care physicians who provide care for critically ill children with CHD in the United States, using the well-established vignette methodology, were randomly assigned different patient scenarios and different genomic information. Physicians then reported their likelihood of recommending particular treatment options for each patient.
RESULTS: Of the participating physicians, 98.3% had seen genetic test results, 84.5% had used results when making recommendations regarding clinical care, 67.5% had seen GS results, and 37.9% had used GS results when making treatment recommendations. In the survey experiments, receipt of GS results predicting intellectual disability, autism, or a childhood onset cancer syndrome each independently significantly reduced the likelihood of physicians recommending surgical palliation, extracorporeal membrane oxygenation or heart transplant.
CONCLUSION: This survey demonstrates that physicians caring for critically ill children with CHD might be influenced by genomic results when making recommendations about whether to forego or withdraw certain treatment options. This raises important ethical issues that should be considered carefully in the future.
参考来源
- Char DS, Deuitch NT, Berent MK, et al. Impact of genomic sequencing information on physicians' treatment recommendations for children with congenital heart disease. Genet Med Open. 2025. PMID: 41431475. doi:10.1016/j.gimo.2025.103470
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。